GLP-1RA pharmacokinetics Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made
Listo para Avanzar
If patients express curiosity about mood benefits from GLP1 receptor agonists, explain that while some evidence exists, current guidelines from organizations such as the American Diabetes Association focus on metabolic outcomes
Data analysis The data were analysed using Statistica version 8 software (Statistica, Tulsa, OK, USA) or GraphPad Prism version 5 software (GraphPad Software Inc., San Diego, CA, USA)